InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

CUP Insider Trading

Insider Ownership Percentage: 20.91%
Insider Buying (Last 12 Months): A$187,036.98
Insider Selling (Last 12 Months): A$0.00

Count Insider Trading History Chart

This chart shows the insider buying and selling history at Count by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Count Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for CUP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

Count Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/19/2024Hugh HumphreyInsiderBuy10,000A$0.58A$5,800.00
3/12/2024Timothy(Tim) MartinInsiderBuy15,000A$0.58A$8,625.00
3/7/2024Timothy(Tim) MartinInsiderBuy15,000A$0.59A$8,775.00
12/27/2023Raymond (Ray) KellermanInsiderBuy35,018A$0.65A$22,761.70
12/21/2023Hugh HumphreyInsiderBuy10,000A$0.66A$6,590.00
12/19/2023Hugh HumphreyInsiderIssued703,468A$0.64A$450,219.52
11/17/2023Hugh HumphreyInsiderBuy7,500A$0.67A$5,025.00
10/2/2023Raymond (Ray) KellermanInsiderBuy23,000A$0.61A$14,099.00
9/28/2023Raymond (Ray) KellermanInsiderBuy159,840A$0.62A$98,621.28
9/22/2023Hugh HumphreyInsiderBuy30,000A$0.56A$16,740.00
3/23/2023Hugh HumphreyInsiderBuy10,000A$0.54A$5,430.00
3/20/2023Hugh HumphreyInsiderBuy10,000A$0.55A$5,530.00
3/13/2023Raymond (Ray) KellermanInsiderBuy202,533A$0.59A$120,102.07
3/10/2023Raymond (Ray) KellermanInsiderBuy147,467A$0.56A$82,434.05
12/9/2022Raymond (Ray) KellermanInsiderBuy100,000A$0.68A$68,000.00
11/18/2022Hugh HumphreyInsiderBuy26,622A$0.69A$18,369.18
11/16/2022Raymond (Ray) KellermanInsiderBuy24,906A$0.68A$16,936.08
9/15/2022Raymond (Ray) KellermanInsiderBuy30,000A$0.79A$23,700.00
9/8/2022Hugh HumphreyInsiderBuy15,000A$0.80A$11,955.00
8/31/2022Raymond (Ray) KellermanInsiderBuy150,000A$0.72A$108,000.00
3/23/2022Raymond (Ray) KellermanInsiderBuy50,810A$0.70A$35,567.00
3/21/2022Raymond (Ray) KellermanInsiderBuy99,190A$0.70A$69,433.00
12/13/2021Matthew RoweInsiderBuy10,000A$1.00A$10,030.00
12/9/2021Matthew RoweInsiderBuy5,000A$0.99A$4,950.00
12/6/2021Raymond (Ray) KellermanInsiderBuy9,000A$0.99A$8,910.00
12/2/2021Matthew RoweInsiderBuy20,000A$0.99A$19,800.00
11/29/2021Raymond (Ray) KellermanInsiderBuy19,000A$0.96A$18,221.00
11/26/2021Raymond (Ray) KellermanInsiderBuy10,000A$0.99A$9,900.00
11/24/2021Matthew RoweInsiderBuy5,590A$1.00A$5,590.00
11/22/2021Matthew RoweInsiderBuy15,903A$1.02A$16,189.25
11/19/2021Matthew RoweInsiderBuy40,844A$1.02A$41,783.41
11/17/2021Matthew RoweInsiderBuy31,054A$1.01A$31,302.43
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Count (ASX:CUP)

29.31% of Count stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Count Limited, together with its subsidiaries, provides accounting, business advisory, and financial planning services in Australia. The company operates through Accounting, Financial Planning, Financial Services, and Other segments. It offers tax, assurance, audit, and corporate advisory services; financial planning; loans commission, and leasing commission services; and information technology, legal, conference, and insurance services. The company was formerly known as CountPlus Limited and changed its name to Count Limited in May 2023. Count Limited was founded in 2006 and is based in Sydney, Australia.
Read More on Count

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

61,836 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

6.70%

Beta

0.63

Who are the company insiders with the largest holdings of Count?

Count's top insider shareholders include:
  1. Hugh Humphrey (Insider)
  2. Raymond (Ray) Kellerman (Insider)
  3. Timothy(Tim) Martin (Insider)
Learn More about top insider investors at Count.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...